EA
ISEE

Emerald Acquisition’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Emerald Acquisition’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$13.8M Buy
299,751
+295,307
+6,645% +$16.7M 0.03% 699
2016
Q2 		$227K Buy
+4,444
New +$221K ﹤0.01% 2702

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Emerald Acquisition's ISEE Position: Q3 2016 in Review

Emerald Acquisition increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 6,645% in Q3 2016, buying an estimated $16.7M and bringing the position to 299,751 shares worth $13.8M. The position accounts for 0.03% of the portfolio, ranked #699.

Emerald Acquisition first reported a position in ISEE in Q2 2016 and has held it in 2 quarters since. 191 funds tracked by Wall St. Rank hold ISEE as of Q3 2016.

  • Emerald Acquisition held 299,751 shares of IVERIC bio, Inc. Common Stock worth $13.8M as of Q3 2016.
  • Emerald Acquisition bought 295,307 IVERIC bio, Inc. Common Stock shares in Q3 2016, an estimated $16.7M.
  • IVERIC bio, Inc. Common Stock made up 0.03% of Emerald Acquisition's portfolio in Q3 2016, its #699 holding.
  • Emerald Acquisition first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and has held it in 2 quarters since.
  • 191 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.